As litigation surrounding GLP-1 receptor agonists like Ozempic and Wegovy advances, the court is now addressing several pivotal issues that could influence the outcome of the case. Below is a summary of the primary challenges under review: 1. Diagnostic Testing for...
![GLP-1 Litigation Update: Key Issues and Upcoming Developments](https://blueskylegal.com/wp-content/uploads/2024/09/GLP-1-1080x675.jpg)